The Minister learned about the projects HIPRA is working on, both in human and animal health, as part of its commitment to strengthening the country’s strategic autonomy.

The Minister for Territory, Housing and Ecological Transition, and spokesperson for the Catalan Government, Sílvia Paneque, visited the new HIPRA Campus facilities in Aiguaviva this friday. The Minister toured this new biotechnology innovation centre, which HIPRA inaugurated in September and which is consolidating its position as one of Europe’s leading hubs for the research, development, production and distribution of vaccines and biotechnology products for global public health.

During her visit to the R&D and Production facilities, the Minister met with members of the management team, who provided a detailed overview of the projects in which HIPRA is involved, such as the European Commission’s SPEEDCELL, the VAX4ASF project against African swine fever project and the company’s contribution to HERA’s EU FAB programme, aimed at strengthening Europe’s health autonomy in the face of future pandemics. She was also informed of the latest updates regarding the inclusion of HIPRA’s COVID-19 vaccine in the 2025–2026 vaccination campaign, following the announcement by the Spanish Ministry of Health.

Minister Sílvia Paneque emphasised that “HIPRA Campus is great news for Girona and for Catalonia. It represents an example of how innovation and research can generate opportunities in the territory, attract and retain talent, and promote a model of sustainable development rooted in the country. Projects like this reinforce Catalonia’s commitment to balanced, knowledge-based growth.”

HIPRA views territorial commitment and equity as key drivers of innovation, talent attraction and the projection of Girona, Catalonia and Spain on the European map of biotechnology and health innovation.